Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD — Stella

Recruiting

Back to Metabolic Dysfunction-associated Steatotic Liver Disease trials

Trial locations(1 site)

Puerto Rico

FDI Clinical Research, San Juan

Key details

Sponsor

Fundacion de Investigacion Science and Education

Enrollment target

~100 participants

Started

July 2024

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

21 Years – 75 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov